Form 4: Dolby CEO Yeaman Exercises Options, Sells Shares

Dolby Laboratories President and CEO Kevin J. Yeaman reported exercising stock options and selling Class A Common Stock on December 9, 2025, through a Rule 10b5-1 plan.

Summary

• Kevin J. Yeaman, President and CEO of Dolby Laboratories, Inc., reported transactions on December 9, 2025.
• Transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Exercised options to acquire 10,615 shares of Class A Common Stock at an exercise price of $64.6 per share.
• Exercised options to acquire 23,752 shares of Class A Common Stock at an exercise price of $45.5 per share.
• Sold 28,168 shares of Class A Common Stock at a weighted average price of $66.9919 per share, with individual transactions ranging from $66.38 to $67.37.
• Sold 6,199 shares of Class A Common Stock at a weighted average price of $67.5052 per share, with individual transactions ranging from $67.39 to $67.60.
• Following these transactions, beneficial ownership includes 98,377 shares indirectly held by a trust, 127,735 shares directly held (underlying restricted stock units subject to forfeiture), and 2.5592 shares indirectly held by a son.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions (option exercises and subsequent sales) conducted under a Rule 10b5-1 plan, which is a common practice for executives to manage their equity holdings. It does not provide operational or financial performance updates, thus maintaining a neutral sentiment regarding the company's prospects.

Positives

• The transactions were conducted under a Rule 10b5-1 plan, indicating pre-planned sales and reducing concerns about opportunistic insider trading.
• The exercise of options suggests the options were in-the-money, allowing the CEO to acquire shares at a lower price than the market sale price, realizing value from past compensation.

Negatives

• The CEO sold a significant number of shares (34,367 shares in total) on the open market, which some investors might interpret as a reduction in personal exposure to the company's stock.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Transactions were conducted by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009.
• Shares are indirectly beneficially owned by a son.

Stakeholder Impact

• Shareholders: The sale of shares by the CEO could be perceived negatively by some investors, though the Rule 10b5-1 plan mitigates concerns about opportunistic selling. The exercise of options indicates the CEO is realizing value from past compensation.

Next Steps

• The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions by Dolby Laboratories' CEO, Kevin J. Yeaman, involving the exercise of stock options and subsequent sale of shares under a pre-arranged Rule 10b5-1 plan. Such transactions are common for executives managing their equity compensation and do not typically signal a change in the company's fundamental outlook or performance. Therefore, based solely on this filing, a 'hold' recommendation is appropriate as it provides no new information to alter an existing investment thesis.

Keywords

Dolby Laboratories, DLB, Insider Trading, Form 4, Stock Options, Share Sale, CEO, Kevin Yeaman, Rule 10b5-1